|
|
|
|
|
|
|
|
|
29.10.26 - 23:01
|
GE Healthcare CEO on 3Q Earnings Beat, Impact of AI (Bloomberg)
|
|
|
Peter Arduini, CEO of GE Healthcare, described radiopharmaceuticals as a fast-growing field that is advancing treatment and care in cancer, cardiology imaging and neurology, including Alzheimer's-related approaches. Because these products have short half-lives and can dissipate by the end of the day, he said control of manufacturing and the supply chain is especially important. He speaks with Romaine Bostick & Kristine Aquino on "The Close,." (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29.10.26 - 00:24
|
Inside The Little-Known Drug Program Making Big Hospitals Billions (ZeroHedge)
|
|
|
Inside The Little-Known Drug Program Making Big Hospitals Billions
Authored by Sylvia Xu, Lawrence Wilson via The Epoch Times,Hospitals that benefit from a government program intended to help safety-net institutions end up spending less on charity care than other hospitals, a new study has found, as federal policymakers move to reform the $244 billion initiative.The 340B Drug Pricing Program allows certain healthcare providers to buy prescription drugs at a steep discount and sell them to patients at retail prices, keeping the difference to supplement their income.The program was created more than 30 years ago to give a financial boost to rural hospitals, hospitals serving a disproportionate share of Medicaid patients, and other safety-net healthcare providers.The Affordable Care Act, also known as Obamacare, allowed many more hospitals to join the program. At the same time, hospitals, physician practices, and other providers were consolidating into large healthcare conglomerates.Within a few ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|